Evogene Announces Exercise of the Company's Series 2 Warrants

REHOVOT, ISRAEL–(Marketwire – Jun 1, 2011) – Evogene Ltd. (TASE: EVGN) announced today that it has received $16.6 million from the exercise of the company's series 2 warrants. The warrants, which expired May 31, 2011, were issued in June 2007 as part …
See all stories on this topic »